Literature DB >> 29092944

Platform for Quantitative Evaluation of Spatial Intratumoral Heterogeneity in Multiplexed Fluorescence Images.

Daniel M Spagnolo1,2, Yousef Al-Kofahi3, Peihong Zhu3, Timothy R Lezon2,4, Albert Gough2,4, Andrew M Stern2,4, Adrian V Lee5,6, Fiona Ginty7, Brion Sarachan3, D Lansing Taylor2,4,5, S Chakra Chennubhotla8.   

Abstract

We introduce THRIVE (Tumor Heterogeneity Research Interactive Visualization Environment), an open-source tool developed to assist cancer researchers in interactive hypothesis testing. The focus of this tool is to quantify spatial intratumoral heterogeneity (ITH), and the interactions between different cell phenotypes and noncellular constituents. Specifically, we foresee applications in phenotyping cells within tumor microenvironments, recognizing tumor boundaries, identifying degrees of immune infiltration and epithelial/stromal separation, and identification of heterotypic signaling networks underlying microdomains. The THRIVE platform provides an integrated workflow for analyzing whole-slide immunofluorescence images and tissue microarrays, including algorithms for segmentation, quantification, and heterogeneity analysis. THRIVE promotes flexible deployment, a maintainable code base using open-source libraries, and an extensible framework for customizing algorithms with ease. THRIVE was designed with highly multiplexed immunofluorescence images in mind, and, by providing a platform to efficiently analyze high-dimensional immunofluorescence signals, we hope to advance these data toward mainstream adoption in cancer research. Cancer Res; 77(21); e71-74. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 29092944      PMCID: PMC5683175          DOI: 10.1158/0008-5472.CAN-17-0676

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Measuring diversity: the importance of species similarity.

Authors:  Tom Leinster; Christina A Cobbold
Journal:  Ecology       Date:  2012-03       Impact factor: 5.499

2.  BioImageXD: an open, general-purpose and high-throughput image-processing platform.

Authors:  Pasi Kankaanpää; Lassi Paavolainen; Silja Tiitta; Mikko Karjalainen; Joacim Päivärinne; Jonna Nieminen; Varpu Marjomäki; Jyrki Heino; Daniel J White
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

3.  Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

Authors:  Sahar M A Mahmoud; Emma Claire Paish; Desmond G Powe; R Douglas Macmillan; Matthew J Grainge; Andrew H S Lee; Ian O Ellis; Andrew R Green
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

5.  Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype.

Authors:  Thomas Jacob; Joe W Gray; Megan Troxell; Tania Q Vu
Journal:  Breast Cancer Res Treat       Date:  2016-08-31       Impact factor: 4.872

Review 6.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

7.  A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity.

Authors:  Bartlomiej Waclaw; Ivana Bozic; Meredith E Pittman; Ralph H Hruban; Bert Vogelstein; Martin A Nowak
Journal:  Nature       Date:  2015-08-26       Impact factor: 49.962

8.  Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.

Authors:  Michael J Gerdes; Christopher J Sevinsky; Anup Sood; Sudeshna Adak; Musodiq O Bello; Alexander Bordwell; Ali Can; Alex Corwin; Sean Dinn; Robert J Filkins; Denise Hollman; Vidya Kamath; Sireesha Kaanumalle; Kevin Kenny; Melinda Larsen; Michael Lazare; Qing Li; Christina Lowes; Colin C McCulloch; Elizabeth McDonough; Michael C Montalto; Zhengyu Pang; Jens Rittscher; Alberto Santamaria-Pang; Brion D Sarachan; Maximilian L Seel; Antti Seppo; Kashan Shaikh; Yunxia Sui; Jingyu Zhang; Fiona Ginty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

9.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes.

Authors:  Anne E Carpenter; Thouis R Jones; Michael R Lamprecht; Colin Clarke; In Han Kang; Ola Friman; David A Guertin; Joo Han Chang; Robert A Lindquist; Jason Moffat; Polina Golland; David M Sabatini
Journal:  Genome Biol       Date:  2006-10-31       Impact factor: 13.583

10.  In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer.

Authors:  Michalina Janiszewska; Lin Liu; Vanessa Almendro; Yanan Kuang; Cloud Paweletz; Rita A Sakr; Britta Weigelt; Ariella B Hanker; Sarat Chandarlapaty; Tari A King; Jorge S Reis-Filho; Carlos L Arteaga; So Yeon Park; Franziska Michor; Kornelia Polyak
Journal:  Nat Genet       Date:  2015-08-24       Impact factor: 38.330

View more
  6 in total

1.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.

Authors:  D Lansing Taylor; Albert Gough; Mark E Schurdak; Lawrence Vernetti; Chakra S Chennubhotla; Daniel Lefever; Fen Pei; James R Faeder; Timothy R Lezon; Andrew M Stern; Ivet Bahar
Journal:  Handb Exp Pharmacol       Date:  2019

2.  Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.

Authors:  Esther P Jane; Daniel R Premkumar; Swetha Thambireddy; Brian Golbourn; Sameer Agnihotri; Kelsey C Bertrand; Stephen C Mack; Max I Myers; Ansuman Chattopadhyay; D Lansing Taylor; Mark E Schurdak; Andrew M Stern; Ian F Pollack
Journal:  Mol Cancer Res       Date:  2020-04-01       Impact factor: 5.852

3.  Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters.

Authors:  Cherry Kim; Ji-Yeon Suh; Changhoe Heo; Chang Kyung Lee; Woo Hyun Shim; Bum Woo Park; Gyunggoo Cho; Do-Wan Lee; Dong-Cheol Woo; Sang-Yeob Kim; Yun Jae Kim; Dong-Jun Bae; Jeong Kon Kim
Journal:  Cancer Med       Date:  2018-07-07       Impact factor: 4.452

4.  Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological System.

Authors:  Mark T Miedel; Dillon C Gavlock; Shanhang Jia; Albert Gough; D Lansing Taylor; Andrew M Stern
Journal:  Sci Rep       Date:  2019-06-06       Impact factor: 4.379

5.  Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence.

Authors:  Katey S S Enfield; Spencer D Martin; Erin A Marshall; Sonia H Y Kung; Paul Gallagher; Katy Milne; Zhaoyang Chen; Brad H Nelson; Stephen Lam; John C English; Calum E MacAulay; Wan L Lam; Martial Guillaud
Journal:  J Immunother Cancer       Date:  2019-01-16       Impact factor: 13.751

Review 6.  Artificial intelligence in clinical and translational science: Successes, challenges and opportunities.

Authors:  Elmer V Bernstam; Paula K Shireman; Funda Meric-Bernstam; Meredith N Zozus; Xiaoqian Jiang; Bradley B Brimhall; Ashley K Windham; Susanne Schmidt; Shyam Visweswaran; Ye Ye; Heath Goodrum; Yaobin Ling; Seemran Barapatre; Michael J Becich
Journal:  Clin Transl Sci       Date:  2021-10-30       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.